Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing next-generation biologics for severe immunological and inflammatory diseases
Provides supply chain security for IT infrastructure
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
Detects, geolocates, and characterizes RF signals using a commercial satellite constellation
Develops inhaled therapies for severe respiratory diseases
Develops medicines targeting historically undruggable protein targets in cancer